Clinical identifiers of complicated Staphylococcus aureus bacteremia.
about
Future challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSAAntibiotics for bacteraemia due to Staphylococcus aureusTreatment for bacteraemia due to Staphylococcus aureusTreatment for bacteraemia due to Staphylococcus aureusMannose-binding lectin-deficient mice are susceptible to infection with Staphylococcus aureusClinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort StudyThe Impact of Infectious Disease Specialist Consultation for Staphylococcus aureus Bloodstream Infections: A Systematic ReviewA Case of Meningococcal Pyomyositis in an Otherwise Healthy AdultStaphylococcus aureus bacteraemia in a tropical setting: patient outcome and impact of antibiotic resistancePotential associations between severity of infection and the presence of virulence-associated genes in clinical strains of Staphylococcus aureusStaphylococcus aureus Bloodstream Infection and Endocarditis--A Prospective Cohort StudyTreatment duration for uncomplicated Staphylococcus aureus bacteremia to prevent relapse: analysis of a prospective observational cohort study.The value of combining blood culture and SeptiFast data for predicting complicated bloodstream infections caused by Gram-positive bacteria or Candida species.MyD88-dependent signaling influences fibrosis and alternative macrophage activation during Staphylococcus aureus biofilm infection.Staphylococcus aureus extracellular adherence protein triggers TNFα release, promoting attachment to endothelial cells via protein A.Clinical manifestations and outcome in Staphylococcus aureus endocarditis among injection drug users and nonaddicts: a prospective study of 74 patientsEpidemiology and outcomes of community-onset methicillin-susceptible Staphylococcus aureus bacteraemia in a university hospital in Singapore.Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus.Thrombocytopenia in Staphylococcus aureus bacteremia: risk factors and prognostic importanceThrombocytopaenia during methicillin-sensitive Staphylococcus aureus bacteraemia.Factors predicting and reducing mortality in patients with invasive Staphylococcus aureus disease in a developing countryClinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of AmericaEvaluating genetic susceptibility to Staphylococcus aureus bacteremia in African Americans using admixture mapping.A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study.Clinical and Microbiological Determinants of Outcome in Staphylococcus aureus BacteraemiaDiffusion of clindamycin-resistant and erythromycin-resistant methicillin-susceptible Staphylococcus aureus (MSSA), potential ST398, in United States Veterans Health Administration Hospitals, 2003-2014.Risk factors for methicillin-resistant Staphylococcus aureus bacteraemia differ depending on the control group chosen.Heterogeneity of the humoral immune response following Staphylococcus aureus bacteremia.Impact of infectious diseases consultation on the management of Staphylococcus aureus bacteraemia in childrenInfective endocarditis at a hospital in Saudi Arabia: epidemiology, bacterial pathogens and outcome.Outcomes with daptomycin in the treatment of Staphylococcus aureus infections with a range of vancomycin MICs.Emerging and resistant infectionsSafety and immunogenicity of a novel Staphylococcus aureus vaccine: results from the first study of the vaccine dose range in humansClinical management of Staphylococcus aureus bacteremia: a review.The role of vancomycin in the persistence or recurrence of Staphylococcus aureus bacteraemia.Persistent catheter-related Staphylococcus aureus bacteremia after catheter removal and initiation of antimicrobial therapy.Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.Molecular epidemiology of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolated from the eyeCharacterization of the humoral immune response during Staphylococcus aureus bacteremia and global gene expression by Staphylococcus aureus in human blood.Risk factors for mortality among patients with Staphylococcus aureus bacteremia: a single-centre retrospective cohort study
P2860
Q22305769-0DD16A40-F19F-410F-9893-3A372D166E06Q24186950-4013EAFE-78F9-4FFE-B412-ADC2D11EE5A2Q24234919-48EAFFAE-87F2-4F24-8919-D8E32CE245CAQ24241085-E97C3084-D174-492F-A851-8C660B7706EEQ24293487-53CF8397-5845-4CDF-8F13-9357876E3ED4Q24634085-C2F43C97-FDC8-4549-A16B-A9580DA71EEDQ26751492-48642808-74B2-43B1-85EB-D840C02E209EQ28069252-FCEDA797-F144-44EC-A50C-97B937A733F2Q28474630-B4371AB1-8338-49B1-A3BE-E04D3357923AQ28477896-8A09DF28-B9F5-4168-91A7-D979AF38C5CBQ28547587-58FC2ACF-9DBA-4DFF-A959-A111568AD35BQ30449846-CA6340DF-CD6F-44D2-954F-A0C88D943A67Q30586802-9D7112F8-1136-4AA2-A3FD-55ABD6D49573Q31083702-3DD67B61-F1BB-4EBA-9A59-A6B9611CD917Q31086401-52E56F72-172B-4398-BA6A-52078680493CQ33257127-E1EC7327-5D23-4775-9E35-3CFAB4C12D97Q33318589-DFFBB1D5-EAF8-4B0F-8FEB-DD2096DF5981Q33378604-482A8267-EB92-4A67-8915-80FF813B2444Q33395120-D65B276F-B9C7-4216-B916-8215DA326B14Q33437851-77ED3E4E-7276-415E-A428-57D3EBA8A07AQ33490115-DDF5BDE7-0A7B-4FF1-8E3C-302842B83B38Q33688646-44619840-A044-4C41-A48B-7B815E9EFC7AQ33701539-3E55918E-BD78-4D42-B3EF-56CE985AEA2FQ33723124-DC7B6EFE-BA08-4199-8EEB-6019D44E8DAAQ33734119-C5348C76-220A-4EDF-92D1-0317D11A4DA7Q33768052-7E7807C7-134F-4C75-A870-CB451B5A5EF8Q33785642-30358B3E-8E2F-4F17-A587-9F3BE78F7EBFQ33788390-01E1DA01-9A1B-48F6-A2F1-AED6C01DE7D4Q33879578-3140D642-9B26-430A-AAD9-09F0A5276154Q33896440-914DF236-3262-497F-9862-9749019A00BAQ33997671-2F48BE35-CAE2-45BB-B1C9-C0EB664AB189Q34357419-4E302E01-442B-4DAB-A072-C2C7DA63663FQ34431997-96D201DC-41C5-4EF8-97A1-71F56CB7C714Q34441035-0281B60C-FDC9-4148-9989-37A5C37BBF40Q34447860-B8B3D0AD-BA5A-43DE-9BE2-352816CD6C94Q34463444-8373960B-BD75-46BC-A551-F85B793A28BEQ34478074-19005EAF-F38A-4DDE-BE57-CEC538E35C77Q34495908-1AE86B57-0726-4D80-9BBA-6F1045B2703AQ34545013-A5C00C24-22F9-4539-BEC4-CA63E47E45F0Q34730284-7CDA595A-7539-4DFF-AE8B-3884C1AC36DE
P2860
Clinical identifiers of complicated Staphylococcus aureus bacteremia.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Clinical identifiers of complicated Staphylococcus aureus bacteremia.
@en
type
label
Clinical identifiers of complicated Staphylococcus aureus bacteremia.
@en
prefLabel
Clinical identifiers of complicated Staphylococcus aureus bacteremia.
@en
P2093
P1476
Clinical identifiers of complicated Staphylococcus aureus bacteremia.
@en
P2093
Christopher H Cabell
Christopher W Woods
Eugene Z Oddone
G Ralph Corey
L Barth Reller
Maren K Olsen
Tara Dudley
P304
P356
10.1001/ARCHINTE.163.17.2066
P407
P577
2003-09-01T00:00:00Z